News
A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...
For our most recent episode of the Fourcast we’ve been speaking to controversial British cardiologist Aseem Malhotra, who was recently appointed as a senior advisor to the US Health Secretary. That ...
GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by ...
StockStory.org on MSN1d
MRNA Q1 Earnings Call: Management Focuses on Cost Reductions and Pipeline Progress Amid Revenue ShortfallBiotechnology company Moderna (NASDAQ:MRNA) in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The ...
Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...
More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.
Explore more
RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines.
HealthDay News — Urticaria is seen in association with experimental HIV-1 mRNA vaccination, according to a study published online April 29 in the Annals of Internal Medicine.
Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...
A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...
K nowing the location of a gene within intact tissue or a single cell allows scientists to unlock unknown cellular functions.
MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results